Average Co-Inventor Count = 5.90
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glaxo Group Limited (8 from 1,168 patents)
2. Glaxosmithkline Intellectual Property Development Limited (5 from 230 patents)
3. Gasherbrum Bio, Inc. (5 from 6 patents)
4. Glaxosmithkline LLC (2 from 356 patents)
5. Smithkline Beecham Corporation (1 from 2,198 patents)
6. Glaxogrouplimited (1 from 8 patents)
7. Lhotse Bio, Inc (2 patents)
22 patents:
1. 12221442 - Heterocyclic GLP-1 agonists
2. 11926643 - Heterocyclic GLP-1 agonists
3. 11926626 - Heterocyclic GLP-1 agonists
4. 11897851 - Heterocyclic GLP-1 agonists
5. 11492365 - Heterocyclic GLP-1 agonists
6. 10336719 - 1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors
7. 10106515 - 1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors
8. 10005731 - Modulators of the retinoid-related orphan receptor gamma (ROR-gamma) for use in the treatment of autoimmune and inflammatory diseases
9. 9902715 - Compounds
10. 9902735 - Heteroaryl substituted compounds as RORγ inhibitors
11. 9868724 - Compounds
12. 8389508 - Heterocyclic compounds
13. 8354416 - 7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase
14. 8354406 - Chemical compounds
15. 8217028 - 1,2,4-oxadiazole indole compounds